Castration-Resistant Cancer

(CRPC)

For patients with advanced prostate cancer that no longer responds to hormone (androgen deprivation) treatment.

 

nMCRPC

Patients with Non-Metastatic Castration-Resistant Prostate Cancer.

MCRPC

Patients with Metastatic Castration-Resistant Prostate Cancer.

MCRPC Small Cell/Neuroendocrine Treatments

Neuroendocrine prostate cancer (NEPC) is an aggressive variant of prostate cancer that may arise in new patients or those previously treated with hormonal therapies for prostate adenocarcinoma as a mechanism of resistance

IMPORTANT:

This information is provided for educational purposes only to support patients in understanding and discussing appropriate treatment options with their doctors. Included is information from treatment guidelines for doctors and other sources. However, this information should not be considered as patient treatment guidelines or recommendations, but as educational materials only. Patients should discuss treatments identified herein with their doctors to understand the risks and benefits of each based on their personal diagnosis. Treatment decisions should only be made between the patient and his doctor.

Pin It on Pinterest